Rupali Ramadas Patil

Psoriasis clinical trials have measured challenges in assessing disease severity and prognosis. Clinical trials require more objectively validated tools. To determine the severity of the skin disease, measurement systems should be objective, reproducible, easy to apply and practically useful. To maintain the objectivity of observations, different s...

Psoriasis is an immune mediated, non infectious, chronic, inflammatory skin disease. It affects approximately 3% of the India’s population and the prevalence is much increasing. The exact cause of psoriasis is not known; however it’s believed both genetic and environmental factors including change in diet and lifestyle can be involved. Several fact...

The color of the skin is important biologically, cosmetically and socially. Vitiligo is an acquired condition where melanocytes are absent in affected area. The worldwide prevalence of Vitiligo is lesser than 1%. Though the condition is rare and non communicable, patients who are suffering from Vitiligo may experience cosmetically disfiguring and p...

According to WHO Sandhivata is the second commonest musculoskeletal problem in the world after backache. The present clinical trial was conducted to evaluate the efficacy of Ptrapinda Sweda and Matra Basti (combined Chikitsa) in the management of Sandhivata. Total 30 patients were selected for clinical trial. All the 30 patients were treated with P...